Requisition update
RNS & Investor News
Temporary Suspension
09 May 2014
The Company notes the recent rise in its share price. The Company confirms that it is in discussions in relation to a possible transaction which, if completed, would constitute a reverse transaction pursuant to the AIM Rules. Consequently, the Company has requested that its shares are temporarily suspended, pending a further announcement.
For further information, please contact:
Ducat Ventures plc | Nicholas Nelson | +44 (0)79 2152 2920 |
Cairn Financial Advisers LLP | Liam Murray / Jo Turner | +44 (0)20 7148 7900 |
Peterhouse Corporate Finance Ltd | Lucy Williams/ Fungai Ndoro | +44 (0)20 7469 0936 |
Latest RNS News
Latest Video
ProBiotix Health anticipating "big commercial opportunities" during 2023
Group CEO Stephen O’Hara and CEO Steen Anderson | 04 January 2023
www.proactiveinvestors.co.uk
Latest Podcast
Stephen OHara interview with Investors Champion
Stephen O'Hara | 04 Jul 2019
www.investorschampion.com